70
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Monocyte galactose/N-acetylgalactosamine-specific C-type lectin receptor stimulant immunotherapy of an experimental glioma. Part II: combination with external radiation improves survival

, , , , , , , , , , & show all
Pages 325-334 | Published online: 17 Sep 2012

References

  • ButowskiNImmunostimulants for malignant gliomasNeurosurg Clin N Am2010211536519944966
  • HigashiNFujiokaKDenda-NagaiKThe macrophage C-type lectin specific for galactose/N-acetylgalactosamine is an endocytic receptor expressed on monocyte-derived immature dendritic cellsJ Biol Chem200227723206862069311919201
  • AbdelwahabMGKuschayevSVKuschayevaYSSynthetic peptide mimetic of macrophage-activating factor in a murine glioma model [abstract]Neuro Oncol2009115613
  • EgginkLLHooberJKA biologically active peptide mimetic of N-acetylgalactosamine/galactoseBMC Res Notes200922319284521
  • NewcombEWLymberisSCLukyanovYRadiation sensitivity of GL261 murine glioma model and enhanced radiation response by flavopiridolCell Cycle200651939916319534
  • NewcombEWTamasdanCEntzmingerYFlavopiridol inhibits the growth of GL261 gliomas in vivo: implications for malignant glioma therapyCell Cycle20043223023414712094
  • YamanakaRCell- and peptide-based immunotherapeutic approaches for gliomaTrends Mol Med200814522823518403264
  • BadieBSchartnerJMFlow cytometric characterization of tumor-associated macrophages in experimental gliomasNeurosurgery200046495796110764271
  • ParneyIFWaldronJSParsaATFlow cytometry and in vitro analysis of human glioma-associated macrophages. Laboratory investigationJ Neurosurg2009110357258219199469
  • RandolphGJJakubzickCQuCAntigen presentation by monocytes and monocyte-derived cellsCurr Opin Immunol2008201526018160272
  • KuschayevSVEgginkLLKuschayevaYSMonocyte galactose/N-acetylgalactosamine-specific C-type lectin receptor stimulant immunotherapy of an experimental glioma. Part I: stimulatory effects on blood monocytes and monocyte-derived cells of the brainCancer Manag Res Forthcoming2012
  • OgdenATHorganDWaziriADefective receptor expression and dendritic cell differentiation of monocytes in glioblastomasNeurosurgery200659490290917038955
  • HallahanDEStaba-HoganMJVirudachalamSKolchinskyAX-ray-induced P-selectin localization to the lumen of tumor blood vesselsCancer Res19985822521652209823335
  • HallahanDEVirudachalamSKuchibhotlaJNuclear factor κB dominant negative genetic constructs inhibit X-ray induction of cell adhesion molecules in the vascular endotheliumCancer Res19985823548454889850083
  • McBrideWHCombining radiation therapy with immunotherapy for treatment of brain tumorsLiauLMBeckerDPCloughesyTFBignerDDBrain Tumor ImmunotherapyTotowa, NJHumana Press2001345362
  • NewcombEWLukyanovYKawashimaNRadiotherapy enhances antitumor effect of anti-CD137 therapy in a mouse glioma modelRadiat Res2010173442643220334514
  • QinDXZhengRTangJLiJXHuYHInfluence of radiation on the blood–brain barrier and optimum time of chemotherapyInt J Radiat Oncol Biol Phys1990196150715102262373
  • SavillJFadokVHensonPHaslettCPhagocyte recognition of cells undergoing apoptosisImmunol Today19931431311368385467
  • De VleeschouwerSFieuwsSRutkowskiSPostoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiformeClin Cancer Res200814103098310418483377
  • MaesWVan GoolSWExperimental immunotherapy for malignant glioma: lessons from two decades of research in the GL261 modelCancer Immunol Immunother201160215316021120655
  • WattersJJSchartnerJMBadieBMicroglia function in brain tumorsJ Neurosci Res200581344745515959903
  • WheelerCJBlackKLLiuGVaccination elicits correlated immune and clinical responses in glioblastoma multiforme patientsCancer Res200868145955596418632651
  • CavalloFDi PierroFGiovarelliMProtective and curative potential of vaccination with interleukin-2-gene-transfected cells from a spontaneous mouse mammary adenocarcinomaCancer Res19935321506750708221636
  • RaychaudhuriSMorrowWJCan soluble antigens induce CD8+ cytotoxic T-cell responses? A paradox revisitedImmunol Today19931473443488363723
  • CelluzziCMFaloLDJrPhysical interaction between dendritic cells and tumor cells results in an immunogen that induces protective and therapeutic tumor rejectionJ Immunol19981607308130859531260
  • KikuchiTAbeTOhnoTEffects of glioma cells on maturation of dendritic cellsJ Neurooncol200258212513012164683
  • WallenfriedmanMAConradJADelaBarreLEffects of continuous localized infusion of granulocyte-macrophage colony-stimulating factor and inoculations of irradiated glioma cells on tumor regressionJ Neurosurg19999061064107110350253
  • JeanWCSpellmanSRWallenfriedmanMAEffects of combined granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2, and interleukin-12 based immunotherapy against intracranial glioma in the ratJ Neurooncol2004661–2394915015768
  • NewcombEWDemariaSLukyanovYThe combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomasClin Cancer Res200612154730473716899624
  • ReitsEAHodgeJWHerbertsCARadiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapyJ Exp Med200620351259127116636135
  • PonomarevEDShriverLPMareszKDittelBNMicroglial cell activation and proliferation precedes the onset of CNS autoimmunityJ Neurosci Res200581337438915959904